Krishna Institute of Medical Sciences Ltd (BOM:543308)
₹ 549.75 4.2 (0.77%) Market Cap: 219.98 Bil Enterprise Value: 232.21 Bil PE Ratio: 69.62 PB Ratio: 12.03 GF Score: 94/100

Q1 2025 Krishna Institute of Medical Sciences Ltd Earnings Call Transcript

Aug 08, 2024 / 04:00AM GMT
Release Date Price: ₹437.66 (+2.17%)

Key Points

Positve
  • Krishna Institute of Medical Sciences Ltd (BOM:543308) reported a gross revenue of INR693 crores, reflecting a growth of 13.8% year-on-year and 8.7% quarter-on-quarter.
  • EBITDA for the quarter stood at INR184 crores, showing a growth of 14.9% year-on-year and 13% quarter-on-quarter, with an EBITDA margin of 26.6%.
  • The company achieved a PAT of INR95.1 crores, up from INR86.7 crores in Q1 FY24 and INR71.6 crores in Q4 FY24.
  • Krishna Institute of Medical Sciences Ltd (BOM:543308) has successfully acquired Queen's NRI Hospital in Vizag, adding a 200-bed facility to its portfolio.
  • The company has been recognized for its excellence in organ transplantation, receiving awards for its achievements in lung transplants and brain stem death certification.
Negative
  • Occupancy rates have declined, with the company now reporting occupancy based on total bed capacity, which has shown a substantial decrease.
  • The Average Length of Stay (ALOS) has been reduced, which may impact revenue per patient metrics.
  • The company is facing challenges in maintaining high occupancy rates in some facilities, particularly in Andhra Pradesh.
  • There is a notable promoter pledge of shares, which the company plans to address by the end of the next quarter.
  • New hospital projects in Thane, Nashik, and Bengaluru are expected to add to the fixed costs and may initially impact margins.
Operator

Ladies and gentlemen, good day, and welcome to KIMS Hospital Q1 FY25 earnings conference call hosted by IIFL Securities Limited. (Operator Instructions)

Please note that this conference is being recorded. I now hand the conference over to Mr. Rahul Jeewani from IIFL Securities Limited. Thank you, and over to you, sir.

Rahul Jeewani
IIFL Securities Limited - Analyst

Yes. Thanks. Good morning, everyone. This is Rahul from IIFL Institutional Equities. I welcome you all to the first quarter earnings conference call of KIMS Hospitals. From KIMS, we have with us Dr. Bhaskara Bollineni, Founder and Managing Director; Dr. Abhinay Bollineni, Executive Director and CEO; and Mr. Sachin Salvi, Chief Financial Officer. Over to you, sir, for your opening comments.

B.Bhaskar Rao
Krishna Institute of Medical Sciences Ltd - Chairman of the Board, Managing Director

(technical difficulty) Let us start on a happy note. Today August 8, is a very important day. It happens to be a National Happiness Happens Day. So I would like

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot